FtsZ: A Novel Target for Tuberculosis Drug Discovery

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 5, 2007-03 ,pp. : 527-543

Bentham Science Publishers

Access to resources Recommend Favorite

The therapeutic potential of GPR120: a patent review

By Halder Somnath   Kumar Sanjay   Sharma Rajiv  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 12, 2013-12 ,pp. : 1581-1590

Informa Healthcare

Access to resources Recommend Favorite

The Synthesis and Antibacterial Activity of Novel 3-O-arylalkylbenzamide Derivatives as FtsZ Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 10, Iss. 4, 2013-01 ,pp. : 320-326

Bentham Science Publishers

Access to resources Recommend Favorite

Glycogen phosphorylase inhibition as a therapeutic target: a review of the recent patent literature

By Baker David J   Greenhaff Paul L   Timmons James A  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 4, 2006-04 ,pp. : 459-466

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic potential of serum and glucocorticoid inducible kinase inhibition

By Lang Florian   Voelkl Jakob  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 6, 2013-09 ,pp. : 701-714

Informa Healthcare

Access to resources Recommend Favorite